About this trial
Extracorporeal Shockwave Therapy (ESWT) is a well-established modality for treating various urological and musculoskeletal conditions. Recently, its application has expanded to include vasculogenic erectile dysfunction (ED), primarily due to its ability to trigger neo-angiogenesis and significantly improve penile blood flow.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with erectile dysfunction (ED) confirmed by clinical assessment and penile duplex Doppler ultrasound
Disqualifiers
1-Coagulapathy. 2-Penile prosthesis. 3-Post Radical Cystectomy 4-Intellectual disability 5-Skeletal abnormalty
Trial design
Single group
Treatments tested in this trial
extracorporeal shock wave therpy
Devicewe will use a Dornier lithotripsy delta 2 for treatment of patient with erectile dysfunction
Treatment groups
Trial outcomes
Primary outcomes
detection of complications from the use of ESWL machine
the patients will be evaluated after the procedure for 1 month to identify any side-effects as hematoma or difficult urination
improvement in the international erectile function score
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: